The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary effects on the innate immune system with the combination of cetuximab and durvalumab in metastatic/ relapsed head and neck squamous cell carcinoma in a phase II trial.
 
Shuchi Gulati
Consulting or Advisory Role - Puma Biotechnology
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Conquer Cancer Foundation
 
Rachel Vachon
No Relationships to Disclose
 
Shireen Desai
No Relationships to Disclose
 
Aubrey Steele
No Relationships to Disclose
 
Sarah Palackdharry
No Relationships to Disclose
 
Vinita Takiar
No Relationships to Disclose
 
Trisha Michel Wise-Draper
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; bexion; Bristol-Myers Squibb; Caris Life Sciences; Merck